Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

LS ARK Genomic Revolution Tracker ETP Securities XS2399368062

1.86
EUR
0.06
EUR
3.13%
20.12.2024
NAV

Nettoinventarwert (NAV)

1.88 USD 0.00 USD 0.22 %
Vortag 1.88 USD Datum 19.12.2024

LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX
LS ARK Genomic Revolution Tracker ETP Securities Chart

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Stellar ETP CH1109575535 308.97%
21Shares Ripple XRP ETP CH0454664043 292.82%
21Shares Sui Staking ETP CH1360612159 266.09%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Algorand ETP CH1146882316 173.59%
21Shares The Sandbox ETP CH1177361008 166.03%
21Shares Injective Staking ETP CH1360612134 43.75%
21Shares Immutable ETP CH1360612142 24.63%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 375.78%
21Shares Stellar ETP CH1109575535 336.18%
21Shares Aave ETP CH1135202120 310.88%
21Shares Algorand ETP CH1146882316 171.25%
21Shares Cardano ETP CH1102728750 151.51%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 275.04%
21Shares Stellar ETP CH1109575535 219.80%
21Shares Aave ETP CH1135202120 209.73%
21Shares Solana staking ETP CH1114873776 184.69%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 177.07%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’648.75%
21Shares Ripple XRP ETP CH0454664043 549.73%
21Shares Bitcoin Core ETP CH1199067674 500.94%
21Shares Bitcoin ETP CH0454664001 485.73%
21Shares Aave ETP CH1135202120 455.94%

Fundamentaldaten

Valor
ISIN XS2399368062
Emittent Leverage Shares PLC
Aufgelegt in Ireland
Auflagedatum 10.12.2021
Kategorie Trading - Leveraged/Inverse Aktien
Währung USD
Volumen 531’962.32
Depotbank
Geschäftsjahresende
Berichtsstand 20.12.2024

Anlagepolitik

So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.

ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities

Performance 1 Jahr
-25.51
Performance 2 Jahre
-24.71
Performance 3 Jahre -
Performance 5 Jahre -
Performance 10 Jahre -